Gen. Ellen Pawlikowski Joins RPM Board of Directors
20 Jul 2022
Acquisition
RPM International Inc. announced the appointment of General (retired) Ellen Pawlikowski to its Board of Directors, effective July 18, 2022. She will stand for election by the stockholders at the 2022 annual meeting.
Pawlikowski is a retired four-star general of the United States Air Force and is an independent consultant, providing expertise to industry and academia on strategic planning, program management, logistics, and research and development. Currently, she serves on the board of defense contractor, Raytheon Technologies, ranked 58 on the 2022 Fortune 500 list. General Pawlikowski is nationally recognized for her leadership and technical management acumen.
Pawlikowski entered the Air Force in 1978 as a distinguished graduate of the ROTC program at the New Jersey Institute of Technology, Newark, NJ. She then attended the University of California at Berkeley and received a doctorate in chemical engineering.
She commanded five times as a general officer and served as the program director and program executive officer for several multibillion-dollar weapon system acquisitions. In her last assignment with the Air Force, she served as commander, Air Force Materiel Command at Wright-Patterson Air Force Base, Ohio.
“Ellen is a remarkable leader with a distinguished background in management, logistics and strategic planning. Her unique perspective will be a considerable asset for RPM’s growth and continued value for our stakeholders,” said Frank C. Sullivan, RPM chairman and CEO.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.